A case of de novo palmoplantar psoriasis with psoriatic arthritis and autoimmune hypothyroidism after receiving nivolumab therapy
| العنوان: | A case of de novo palmoplantar psoriasis with psoriatic arthritis and autoimmune hypothyroidism after receiving nivolumab therapy |
|---|---|
| المؤلفون: | Ana Pampín-Franco, Marta Elosua-González, Xabier Mielgo-Rubio, Ximena Rodriguez-Vasquez, Elena García-Zamora, José Luis López-Estebaranz, Ramón Mazzucchelli-Esteban |
| المصدر: | Elosua-González, Marta; Pampín-Franco, Ana; Mazzucchelli-Esteban, Ramón; Mielgo-Rubio, Xabier; Rodriguez-Vásquez, Ximena; García-Zamora, Elena; et al.(2017). A case of de novo palmoplantar psoriasis with psoriatic arthritis and autoimmune hypothyroidism after receiving nivolumab therapy. Dermatology Online Journal, 23(8). Retrieved from: http://www.escholarship.org/uc/item/12n4m6pm Europe PubMed Central Scopus-Elsevier |
| بيانات النشر: | eScholarship, University of California, 2017. |
| سنة النشر: | 2017 |
| مصطلحات موضوعية: | Male, medicine.medical_specialty, Lung Neoplasms, Arthritis, Antineoplastic Agents, Dermatology, Hashimoto Disease, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Psoriasis, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Lung cancer, Adverse effect, Aged, 030203 arthritis & rheumatology, business.industry, Melanoma, Arthritis, Psoriatic, Thyroiditis, Autoimmune, Cancer, Antibodies, Monoclonal, General Medicine, medicine.disease, Nivolumab, nivolumab, psoriasis, arthritis, anti-PD-1, autoimmune hypothyroidism, business |
| الوصف: | Nivolumab, a monoclonal antibody against the programmed cell death protein 1 (PD-1), has shown promising results in patients with advanced malignancies, including melanoma, lung cancer, and renal cancer. Immune-related adverse events (irAEs) have been reported, including both organ-specific toxicities and skin toxicities. Herein, we report a case of predominantly palmoplantar psoriasis with severe nail involvement, psoriatic arthritis, and autoimmune hypothyroidism after receiving nivolumab treatment for lung cancer. We also summarize the case reports that have been published previously. The knowledge of these irAEs in patients undergoing anti-PD1 therapy is important since it will enable earlier recognition and appropriate management, with the aim of maintaining effective dose without disruption. |
| وصف الملف: | application/pdf |
| اللغة: | English |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba96bed287a53bf62c815ee61ed7f4af http://www.escholarship.org/uc/item/12n4m6pm |
| Rights: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....ba96bed287a53bf62c815ee61ed7f4af |
| قاعدة البيانات: | OpenAIRE |
| الوصف غير متاح. |